In-house IP roundup: Charities seek better IP deals; medical device start-ups' patent catch-22; USPTO eligibility guidance creates consistency

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

In-house IP roundup: Charities seek better IP deals; medical device start-ups' patent catch-22; USPTO eligibility guidance creates consistency

Flying money

Managing IP rounds up the latest news and analysis from patent-focused businesses

Piggy

Donation drop pushes medical funders to seek better IP deals

Healthcare charity IP managers say they are negotiating fairer patent commercialisation and management arrangements with universities to replace falling revenue streams and generate cash for new projects. Read more ...




MoneyMedical device start-ups face patent investment catch-22

Fledgling businesses in the medical device sector must spend enormous sums of money developing and protecting their inventions to penetrate the market and attract investment. But they often only have enough start-up money for one of those needs. Read more ...





image1USPTO eligibility guidance could create consistency for tech and life sciences

Barclays, Regeneron, Amadeus and others say the new guidance on Section 101-related subject matter could lead to more reliable patent examinations – and may mark the start of a post-Alice framework reversal. Read more ...







Sign up
 to receive more content like this in Patent Strategy’s weekly newsletter.





more from across site and SHARED ros bottom lb

More from across our site

The tie-up could result in the firm’s German and France-based teams, which both have strong UPC expertise, becoming independent
News of a slowdown in the UK’s clean energy IP landscape and an EPO report on unitary patent uptake were also among the top talking points
Price hikes at ‘big law’ firms are pushing some clients toward boutiques that offer predictable fees, specialised expertise, and a model built around prioritising IP
The Australian side, in particular, can benefit by capitalising on its independent status to bring in more work from Western countries while still working with its former Chinese partner
Koen Bijvank of Brinkhof and Johannes Heselberger of Bardehle Pagenberg discuss the Amgen v Sanofi case and why it will be cited frequently
View the official winners of the 2025 Social Impact EMEA Awards
King & Wood Mallesons will break into two entities, 14 years after a merger between a Chinese and an Australian firm created the combined outfit
Teams from Shakespeare Martineau and DWF will take centre stage in a dispute concerning the registrability of dairy terminology in plant-based products
Senem Kayahan, attorney and founder at PatentSe, discusses how she divides prosecution tasks, and reveals the importance of empathetic client advice
The association’s Australian group has filed a formal complaint against the choice of venue, citing Dubai as an unsafe environment for the LGBTQIA+ community
Gift this article